Daily Stock Market Report (Fri 20th February 2026) - CHRY, SWC

Good morning! Let's see what Friday's news feed has for us.

Today's Agenda is complete. Spreadsheet accompanying this report: link.

Companies Reporting
Name (Mkt Cap)RNSSummaryOur View (Author)AstraZeneca (LON:AZN) (£237bn | SR79)Fixed-duration Calquence combo approved in USAstraZeneca's Calquence in combination with venetoclax has been approved in the US as the first all-oral, fixed-duration regimen for the treatment of adult patients with chronic lymphocytic leukaemia and small lymphocytic lymphoma.Anglo American (LON:AAL) (£42bn | SR55)Full year 2025 ResultsUnderlying EBITDA of $6.4 billion (2024: $6.3 billion). $1.8 billion of run-rate cost savings delivered. Loss of $3.7 billion, including a pre-tax impairment of $2.3 billion relating to De Beers.SEGRO (LON:SGRO) (£10.8bn | SR77)Results for the year ended 31 December 2025£99 million of new contracted rent commitments and 6.0 per cent growth in like-for-like net rental income. Estimated Rental Value +3.1 per cent in the UK. Occupancy increased 90 bps to 94.9%. Adjusted pre-tax profit +8.3% to £509m.TBC Bank (LON:TBCG) (£2.4bn | SR65)4Q and FY 2025 Results ReportFY 2025 profit of 1,420 million Georgian Lari, up by 9% YoY, with ROE at 24.2%. As outlined in the...